VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HALO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HALOHalozyme Therapeutics, Inc.
$81.57$9.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHALOQuarterly Financials

Halozyme Therapeutics, Inc. (HALO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Halozyme Therapeutics, Inc. (HALO) quarterly income statement — complete revenue, gross profit & net income history

HALO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue376.71M451.77M354.26M325.72M264.86M298.01M290.08M231.35M195.88M230.04M216.03M221.04M162.14M181.5M208.98M152.37M117.28M102M115.83M136.46M
Revenue Growth %42.23%51.6%22.12%40.79%35.22%29.55%34.28%4.67%20.81%26.75%3.38%45.07%38.25%77.93%80.42%11.66%31.74%-16.19%77.34%147.11%
Cost of Goods Sold108.75M102.15M73M64.12M66.17M42.05M49.43M57.37M46.09M52.3M54.82M50.07M35.17M42.12M47.32M33.94M15.92M21.59M18.59M23.02M
COGS % of Revenue28.87%22.61%20.61%19.69%24.98%14.11%17.04%24.8%23.53%22.73%25.38%22.65%21.69%23.21%22.64%22.28%13.58%21.16%16.05%16.87%
Gross Profit267.96M349.62M281.26M261.6M198.7M255.95M240.66M173.98M149.79M177.74M161.21M170.97M126.97M139.38M161.66M118.42M101.36M80.42M97.24M113.44M
Gross Margin %71.13%77.39%79.39%80.31%75.02%85.89%82.96%75.2%76.47%77.27%74.62%77.35%78.31%76.79%77.36%77.72%86.42%78.84%83.95%83.13%
Gross Profit Growth %34.86%36.6%16.87%50.36%32.65%44%49.28%1.76%17.97%27.53%-0.28%44.37%25.27%73.32%66.24%4.39%43.15%-15.73%62.75%129.25%
Operating Expenses83.44M95.22M63.34M59.16M57.16M80.45M77.46M56.75M54.24M76.71M72.93M76.51M73.17M64.87M78.36M84.36M25.69M23.88M21.66M20.39M
OpEx % of Revenue22.15%21.08%17.88%18.16%21.58%27%26.7%24.53%27.69%33.34%33.76%34.61%45.13%35.74%37.5%55.37%21.9%23.41%18.7%14.94%
Selling, General & Admin57.88M63.33M46.09M41.61M42.36M42.25M41.24M35.71M35.13M37.61M35.27M38.95M37.36M37.75M34.47M57.48M13.83M13.77M13.17M12.32M
SG&A % of Revenue15.37%14.02%13.01%12.78%15.99%14.18%14.22%15.44%17.94%16.35%16.33%17.62%23.04%20.8%16.49%37.72%11.8%13.5%11.37%9.03%
Research & Development25.56M31.9M17.25M17.54M14.8M20.44M18.46M21.04M19.11M21.34M17.32M19.73M17.98M22.57M16.7M15.48M11.85M10.11M8.49M8.07M
R&D % of Revenue6.79%7.06%4.87%5.39%5.59%6.86%6.36%9.09%9.76%9.27%8.02%8.92%11.09%12.43%7.99%10.16%10.11%9.91%7.33%5.91%
Other Operating Expenses000001000K1000K001000K1000K1000K1000K1000K1000K1000K0000
Operating Income184.52M254.4M217.92M202.44M141.53M175.5M163.2M117.23M95.54M101.03M88.28M94.46M53.8M74.51M83.29M34.06M75.67M56.53M75.59M93.05M
Operating Margin %48.98%56.31%61.51%62.15%53.44%58.89%56.26%50.67%48.78%43.92%40.86%42.73%33.18%41.05%39.86%22.35%64.52%55.42%65.26%68.19%
Operating Income Growth %30.37%44.95%33.53%72.68%48.14%73.7%84.86%24.11%77.58%35.6%5.99%177.33%-28.9%31.8%10.2%-63.39%49.15%-27.17%87.56%214.83%
EBITDA218.25M281.08M238.38M222.9M161.98M195.92M183.56M137.6M115.75M121.73M111.32M115.09M74.26M81.62M112.48M46.56M76.45M57.31M76.29M93.85M
EBITDA Margin %57.94%62.22%67.29%68.43%61.16%65.74%63.28%59.47%59.09%52.92%51.53%52.07%45.8%44.97%53.83%30.56%65.18%56.18%65.86%68.78%
EBITDA Growth %34.74%43.47%29.87%62%39.95%60.95%64.89%19.55%55.87%49.13%-1.04%147.18%-2.86%42.43%47.45%-50.38%48.52%-26.93%85.6%208.92%
D&A (Non-Cash Add-back)33.73M26.68M20.46M20.46M20.45M20.41M20.36M20.36M20.21M20.69M23.04M20.64M20.46M7.11M29.19M12.5M778K773K700K800K
EBIT184.52M254.4M217.92M202.44M141.53M182.75M169.67M117.23M95.54M106.39M106.27M97.65M56.78M75.36M81.22M33.12M75.67M56.87M75.59M93.05M
Net Interest Income-4.19M-4.91M1.04M2.5M-4.53M-4.54M-4.52M-4.52M-4.51M-5.22M-4.5M-4.49M-4.54M-4.57M-7.51M-3.1M-1.76M-2.06M-1.75M-1.75M
Interest Income1.32M05.33M6.89M0000000000000000
Interest Expense5.51M4.91M4.3M4.39M4.53M4.54M4.52M4.52M4.51M5.22M4.5M4.49M4.54M4.57M7.51M3.1M1.76M2.06M1.75M1.75M
Other Income/Expense-4.19M-355.25M1.04M2.5M2.29M2.71M1.95M508K486K140K13.48M-1.3M-1.56M-3.72M-9.59M-4.05M-1.26M-1.72M-1.48M-1.53M
Pretax Income180.33M-100.85M218.96M204.94M143.83M178.21M165.15M117.74M96.03M101.17M101.76M93.16M52.24M70.79M73.71M30.01M74.41M54.81M74.11M91.52M
Pretax Margin %47.87%-22.32%61.81%62.92%54.3%59.8%56.93%50.89%49.02%43.98%47.1%42.14%32.22%39%35.27%19.7%63.45%53.73%63.98%67.07%
Income Tax30.28M40.74M43.73M39.78M25.73M41.2M28.14M24.5M19.2M15.79M19.92M18.4M12.62M13.09M12.07M7.33M14.3M-11.96M-142.48M58K
Effective Tax Rate %16.79%-40.4%19.97%19.41%17.89%23.12%17.04%20.81%20%15.6%19.58%19.75%24.16%18.49%16.38%24.41%19.22%-21.82%-192.27%0.06%
Net Income150.05M-141.59M175.22M165.16M118.09M137.01M137.01M93.25M76.82M85.39M81.84M74.75M39.62M57.7M61.63M22.68M60.11M66.77M216.59M91.46M
Net Margin %39.83%-31.34%49.46%50.71%44.59%45.98%47.23%40.3%39.22%37.12%37.88%33.82%24.43%31.79%29.49%14.89%51.25%65.46%186.99%67.02%
Net Income Growth %27.06%-203.34%27.89%77.12%53.72%60.46%67.42%24.74%93.92%47.98%32.78%229.53%-34.09%-13.58%-71.54%-75.2%115.48%-8.74%498.19%254.25%
Net Income (Continuing)150.05M-141.59M175.22M165.16M118.09M137.01M137.01M93.25M76.82M85.39M81.84M74.75M39.62M57.7M61.63M22.68M60.11M66.77M216.59M91.46M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.22-1.201.431.330.931.061.050.720.600.650.610.560.290.420.440.160.430.461.480.62
EPS Growth %31.18%-213.21%36.19%84.72%55%63.08%72.13%28.57%106.9%54.76%38.64%250%-32.56%-8.7%-70.27%-74.19%126.32%-8%492%226.32%
EPS (Basic)1.27-1.201.491.360.961.081.080.730.610.660.620.570.290.430.450.160.440.481.530.64
Diluted Shares Outstanding122.88M117.67M122.33M124.16M126.64M129.42M130.13M129.22M128.89M131.03M134.08M133.54M137.9M138.6M139.39M142.22M141.28M144.25M146.69M147.62M
Basic Shares Outstanding118.14M117.67M117.22M121.34M123.22M126.41M126.85M127.12M126.94M129.05M131.97M131.73M135.03M135.28M136.53M137.94M137.66M140.22M142.02M142.49M
Dividend Payout Ratio--------------------